RAC2 and melanoma: Furthermore, in this study, the primary Rac effector of neuroblastoma appeared to be Rac2, as opposed to Rac1 in melanoma, prostate cancer, breast cancer, and liver cancer (13, 15, 18, 29, 34, 41, 42).